ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is and the CUSIP is 69329Y10. A total of 4 filers reported holding PDL BIOPHARMA INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2016$1,223,000
-6.4%
365,050
-12.2%
0.00%0.0%
Q2 2016$1,306,000
-32.5%
415,858
-28.4%
0.00%
-50.0%
Q1 2016$1,935,000
+5.5%
580,969
+12.2%
0.01%0.0%
Q4 2015$1,834,000
+422.5%
518,000
+642.1%
0.01%
+700.0%
Q3 2015$351,000
-95.5%
69,800
-92.6%
0.00%
-97.9%
Q1 2014$7,839,000
-49.4%
943,334
-48.6%
0.05%
-44.0%
Q4 2013$15,491,000
+48.4%
1,835,437
+40.2%
0.08%
+27.3%
Q3 2013$10,436,000
-5.3%
1,309,377
-8.3%
0.07%
-19.5%
Q2 2013$11,019,0001,427,3240.08%
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2013
NameSharesValueWeighting ↓
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1,309,377$10,436,0000.07%
NJ State Employees Deferred Compensation Plan 8,000$64,0000.01%
INGALLS & SNYDER LLC 25,600$204,0000.01%
State of New Jersey Common Pension Fund A 245,000$1,953,0000.01%
View complete list of PDL BIOPHARMA INC shareholders